Benzinga's Top Initiations
Janney Capital initiated coverage on shares of Salix Pharmaceuticals (NASDAQ: SLXP) with a “buy” rating. The target price for Salix is set to $55. Salix's shares closed at $47.21 yesterday.
Analysts at Leerink initiated coverage on shares of Santarus (NASDAQ: SNTS) with a “outperform” rating. Santarus' shares closed at $12.93 yesterday.
JP Morgan initiated coverage on shares of Infinity Pharmaceuticals (NASDAQ: INFI) with an “overweight” rating. The target price for Infinity Pharmaceuticals is set to $42. Infinity Pharmaceuticals' stock closed at $33.37 yesterday.
Analysts at Janney Capital initiated coverage on shares of Forest Laboratories (NYSE: FRX) with a “buy” rating. The target price for Forest Labs is set to $45. Forest Labs' shares closed at $36.28 yesterday.
Latest Ratings for SNTS
|Dec 2013||Stifel Nicolaus||Downgrades||Buy||Hold|
|Nov 2013||Roth Capital||Downgrades||Buy||Neutral|
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.